Logo Image
News
OncClubAll Oncology NewsClinical Trials in Focus
Media
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid ReadoutsShorts
Conferences
Conference CoverageConference Listing
Events
Giants of Cancer CareCME/CEScientific InterchangesState of the Science SummitNational Fellows ForumWebinars
More
Partners
Publications
All PublicationsSupplements
Resources
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker Consortium

Subscribe

  • News
  • Media
  • Conferences
  • Events
  • Partners
  • Publications
  • Resources
  • Biomarker Consortium
  • Subscribe
  • AI for Oncology
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
    • HER2+ Breast Cancer
  • CAR T-Cell Therapy
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
    • Pancreatic Cancer
    • Hepatocellular Carcinoma
    • Gastric Cancer
    • Colorectal Cancer
  • Genitourinary Cancers
    • Urothelial Cancer
    • Prostate Cancer
  • Global Oncology
  • Graft-vs-Host Disease
  • Gynecologic Oncology
    • Ovarian Cancer
  • Head & Neck Cancers
  • Hematologic Oncology
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myeloproliferative Neoplasms
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Oncology Business Management
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Sarcomas
  • Supportive Care
Spotlight -
The OncLive Insider app is live!|
CME Opportunities
Advertisement

Practical Guide on the Use of Immunotherapy in Melanoma

EP. 1: Team Approach to Advanced Melanoma Treatment at MSKCC

February 8th 2017

EP. 2: Multidisciplinary Care for Advanced Melanoma at Georgetown University

February 8th 2017

EP. 3: Explaining Therapeutic Options to Patients With Advanced Melanoma

February 8th 2017

EP. 4: Initial Treatment Approach in Advanced Melanoma: Factors to Consider

February 8th 2017

EP. 5: Immunotherapy in BRAF Wild-Type Melanoma

February 8th 2017

EP. 6: BRAF-Mutant Melanoma: Frontline Decisions

February 8th 2017

EP. 7: Melanoma: Speed and Durability of Therapeutic Response

February 8th 2017

EP. 8: Monotherapy Versus Combination Therapy Approaches in Melanoma

February 8th 2017

EP. 9: Overall Toxicities With Immunotherapy in Melanoma

February 8th 2017

EP. 10: Melanoma: Management of Dermatologic Toxicities

February 8th 2017

EP. 11: Managing Gastrointestinal Toxicities in Melanoma

February 8th 2017

EP. 12: Immunotherapy-Related Pulmonary Toxicities in Melanoma

February 8th 2017

EP. 13: Melanoma: Testing for Immunotherapy-Related Hepatotoxicity

February 8th 2017

EP. 14: Immunotherapy in Melanoma: Recognizing an Endocrinopathy

February 8th 2017

EP. 15: Less Common Side Effects With Immunotherapy in Melanoma

February 8th 2017
Advertisement
Advertisement

Trending on OncLive

1

FDA Approves Bioequivalent Olaparib Across Previously Approved Cancer Indications

2

Longer-Term Data Help Shape TKI Selection in ROS1+ and ALK+ NSCLC

3

Experts Revisit the Most Notable Data in GU Oncology From ASCO 2026

4

Dr Mardones on Giredestrant Plus Palbociclib in Estrogen Receptor+ Breast Cancer

5

Sacituzumab Govitecan Yields Responses in Platinum-Resistant Ovarian Cancer

  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo
Download on Apple
Download on Google Play

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us